Association of the functional A118G polymorphism of OPRM1 in diabetic patients with foot ulcer pain

Journal of Diabetes and its Complications

Volumn 24, Issue 2, 2010, Pages 102-108

  Cheng, Kuang I ^a,b,c   Lin, Shiu Ru ^d   Chang, Lin Li ^a   Wang, Jaw Yuan ^b,c,e   Lai, Chung Sheng ^b,c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c Department of Otorhinolaryngology Head and Neck Surgery   (Taiwan)

^d FOOYIN UNIVERSITY   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Diabetes; Foot ulcer pain; Mu opioid receptor; OPRM1; Single nucleotide polymorphism

Indexed keywords

DNA FRAGMENT; MU 1 OPIATE RECEPTOR; MU OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIABETES MELLITUS; DIABETIC FOOT; DIABETIC NEUROPATHY; DNA POLYMORPHISM; DNA SEQUENCE; FEMALE; FOOT PAIN; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; DIABETIC NEUROPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PAIN; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, OPIOID, MU;

EID: 76949106427     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2009.02.003     Document Type: Article

References (34)

1. Abetz L., Sutton M., Brady L., McNulty P., and Gagnon D. The Diabetic Foot Ulcer Scale (DFS): A quality of life instrument for use in clinical trials. Practical Diabetes International 19 (2002) 167-175
2. Bond C., LaForge K.S., Tian M., Melia D., Zhang S., et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: Possible implications for opiate addiction. Proceedings of the National Academy of Sciences of the United States of America 95 (1998) 9608-9613
3. Boulton A.J., Gries F.A., and Jervell J.A. Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabetic Medicine 15 (1998) 508-514
4. Boyko E.J., Ahroni J.H., Stensel V., Forsberg R.C., Davignon D.R., and Smith D.G. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care 22 (1999) 1036-1042
5. Carrington A.L., Mawdsley S.K., Morley M., Kincey J., and Boulton A.J. Psychological status of diabetic people with or without lower limb disability. Diabetes Research and Clinical Practice 32 (1996) 19-25
6. Chou W.Y., Yang L.C., Lu H.F., Ko J.Y., Wang C.H., et al. Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty. Acta Anaesthesiologica Scandinavica 50 (2006) 787-792
7. Crowley J.J., Oslin D.W., Patkar A.A., Gottheil E., DeMaria P.A., et al. A genetic association study of the mu opioid receptor and severe opioid dependence. Psychiatric Genetics 13 (2003) 169-173
8. Dolan N.C., Liu K., Criqui M.H., Greenland P., Guralnik J.M., et al. Peripheral artery disease, diabetes, and reduced lower extremity functioning. Diabetes Care 25 (2002) 113-120
9. Evans A.R., and Pinzur M.S. Health-related quality of life of patients with diabetes and foot ulcers. Foot & Ankle International 26 (2005) 32-37
10. Faglia E., Mantero M., Caminiti M., Caravaggi C., De Giglio R., et al. Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: Clinical results of a multicentric study of 221 consecutive diabetic subjects. Journal of Internal Medicine 252 (2002) 225-232
11. Fillingim R.B., Kaplan L., Staud R., Ness T.J., Glover T.L., et al. The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. Journal of Pain 6 (2005) 159-167
12. Freedman G., Cean C., Duron V., Tarnovskaya A., and Brem H. Pathogenesis and treatment of pain in patients with chronic wounds. Surgical Technology International 11 (2003) 168-179
13. Gregg E.W., Sorlie P., Paulose-Ram R., Gu Q., Eberhardt M.S., et al. Prevalence of lower-extremity disease in the US adult population ≥40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. Diabetes Care 27 (2004) 1591-1597
14. Grosch S., Niederberger E., Lotsch J., Skarke C., and Geisslinger G. A rapid screening method for a single nucleotide polymorphism (SNP) in the human MOR gene. British Journal of Clinical Pharmacology 52 (2001) 711-714
15. Janicki P.K., Schuler G., Francis D., Bohr A., Gordin V., et al. A genetic association study of the functional A118G polymorphism of the human mu-opioid receptor gene in patients with acute and chronic pain. Anesthesia and Analgesia 103 (2006) 1011-1017
16. Kim S.G., Kim C.M., Kang D.H., Kim Y.J., Byun W.T., et al. Association of functional opioid receptor genotypes with alcohol dependence in Koreans. Alcoholism, Clinical and Experimental Research 28 (2004) 986-990
17. Kiziltan M.E., Gunduz A., Kiziltan G., Akalin M.A., and Uzun N. Peripheral neuropathy in patients with diabetic foot ulcers: Clinical and nerve conduction study. Journal of Neurological Sciences 258 (2007) 75-79
18. Landau R., Cahana A., Smiley R.M., Antonarakis S.E., and Blouin J.L. Genetic variability of mu-opioid receptor in an obstetric population. Anesthesiology 100 (2004) 1030-1033
19. Lotsch J., Stuck B., and Hummel T. The human mu-opioid receptor gene polymorphism 118A > G decreases cortical activation in response to specific nociceptive stimulation. Behavioral Neuroscience 120 (2006) 1218-1224
20. Low P.A., and Dotson R.M. Symptomatic treatment of painful neuropathy. JAMA 280 (1998) 1863-1864
21. Mayfield J.A., Reiber G.E., Sanders L.J., Janisse D., and Pogach L.M. Preventive foot care in people with diabetes. Diabetes Care 26 (2003) S78-S79
22. Nishizawa D., Han W., Hasegawa J., Ishida T., Numata Y., et al. Association of micro-opioid receptor gene polymorphism A118G with alcohol dependence in a Japanese population. Neuropsychobiology 53 (2006) 137-141
23. Oyibo S.O., Jude E.B., Tarawneh I., Nguyen H.C., Harkless L.B., and Boulton A.J. A comparison of two diabetic foot ulcer classification systems: The Wagner and the University of Texas wound classification systems. Diabetes Care 24 (2001) 84-88
24. Reddy M., Kohr R., Queen D., Keast D., and Sibbald R.G. Practical treatment of wound pain and trauma: A patient-centered approach. An overview. Ostomy/Wound Management 49 (2003) 2-15
25. Ribu L., Rustoen T., Birkeland K., Hanestad B.R., Paul S.M., and Miaskowski C. The prevalence and occurrence of diabetic foot ulcer pain and its impact on health-related quality of life. Journal of Pain 7 (2006) 290-299
26. Ribu L., and Wahl A. Living with diabetic foot ulcers: A life of fear, restrictions, and pain. Ostomy/Wound Management 50 (2004) 57-67
27. Rijken P.M., Dekker J., Dekker E., Lankhorst G.J., Bakker K., et al. Clinical and functional correlates of foot pain in diabetic patients. Disability and Rehabilitation 20 (1998) 330-336
28. Sia A.T., Lim Y., Lim E.C., Goh R.W., Law H.Y., et al. A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia. Anesthesiology 109 (2008) 520-526
29. Sibbald R.G., Armstrong D.G., and Orsted H.L. Pain in diabetic foot ulcers. Ostomy/Wound Management 49 (2003) 24-29
30. Singh N., Armstrong D.G., and Lipsky B.A. Preventing foot ulcers in patients with diabetes. JAMA 293 (2005) 217-228
31. Tan E.C., Tan C.H., Karupathivan U., and Yap E.P. Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations. Neuroreport 14 (2003) 569-572
32. Ulbrecht J.S., Cavanagh P.R., and Caputo G.M. Foot problems in diabetes: An overview. Clinical Infectious Diseases 39 (2004) S73-S82
33. Wand G.S., McCaul M., Yang X., Reynolds J., Gotjen D., et al. The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade. Neuropsychopharmacology 26 (2002) 106-114
34. Zadina J.E., Hackler L., Ge L.J., and Kastin A.J. A potent and selective endogenous agonist for the mu-opiate receptor. Nature 386 (1997) 499-502